307 related articles for article (PubMed ID: 32599499)
1. Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis.
Forner D; Noel CW; Wu V; Parmar A; Chan KKW; de Almeida JR; Husain Z; Eskander A
Oral Oncol; 2020 Oct; 109():104849. PubMed ID: 32599499
[TBL] [Abstract][Full Text] [Related]
2. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Sjoquist KM; Burmeister BH; Smithers BM; Zalcberg JR; Simes RJ; Barbour A; Gebski V;
Lancet Oncol; 2011 Jul; 12(7):681-92. PubMed ID: 21684205
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI
Cochrane Database Syst Rev; 2011 Apr; (4):CD006386. PubMed ID: 21491393
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ;
Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.
Bulsara VM; Worthington HV; Glenny AM; Clarkson JE; Conway DI; Macluskey M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006205. PubMed ID: 30582609
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?
Chu C; Sun Y; Pan Y
Oral Oncol; 2020 Aug; 107():104860. PubMed ID: 32571643
[No Abstract] [Full Text] [Related]
8. Survival Impact of Surgical Resection in Locally Advanced T4b Oral Squamous Cell Carcinoma.
Gangopadhyay A; Bhatt S; Nandy K; Rai S; Rathod P; Puj KS
Laryngoscope; 2021 Jul; 131(7):E2266-E2274. PubMed ID: 33459389
[TBL] [Abstract][Full Text] [Related]
9. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
Gasparri ML; Gentilini OD; Lueftner D; Kuehn T; Kaidar-Person O; Poortmans P
Breast; 2020 Aug; 52():110-115. PubMed ID: 32502796
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
11. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Parmar A; Macluskey M; Mc Goldrick N; Conway DI; Glenny AM; Clarkson JE; Worthington HV; Chan KK
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006386. PubMed ID: 34929047
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of primary radiotherapy with or without chemotherapy for advanced oral cavity squamous cell carcinoma: Systematic review.
Membreno PV; Luttrell JB; Mamidala MP; Schwartz DL; Hayes DN; Gleysteen JP; Gillespie MB
Head Neck; 2021 Oct; 43(10):3165-3176. PubMed ID: 34165221
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
15. 'Doing as little as possible and as much as necessary' - Oncological efficacy of marginal mandibulectomy in resection of oral cavity cancers.
Suresh S; Thomas S; Janardhan D; Patil S; George NA; Varghese BT; Iype EM; Rafi M; George CK
Oral Oncol; 2019 Aug; 95():91-94. PubMed ID: 31345400
[TBL] [Abstract][Full Text] [Related]
16. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
Gootee J; Patel M; Aurit S; Silberstein P
Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.
Kranzfelder M; Schuster T; Geinitz H; Friess H; Büchler P
Br J Surg; 2011 Jun; 98(6):768-83. PubMed ID: 21462364
[TBL] [Abstract][Full Text] [Related]
19. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]